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NMB with rocuronium bromide reduced skeletal muscular 
VO 2 and total body O 2 extraction rate. As the cardiac index 
increased simultaneously, total body VO 2 only decreased 
marginally in the Roc group (change of VO 2 relative to base-
line –1.7  8 0.8 vs. 3.2  8 1.9% in the Sal group, p  ! 0.05).  Con-
clusion: Deep NMB with rocuronium bromide increases the 
tolerance of acute normovolemic anemia. The underlying 
mechanism most likely involves a reduction of skeletal mus-
cular VO 2 . During acellular treatment of an acute blood loss, 
NMB might play an adjuvant role in situations where pro-
found stages of normovolemic anemia have to be tolerated 
(e.g. bridging an unexpected blood loss until blood prod-
ucts become available for transfusion). 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 The initial treatment of an acute blood loss usually 
consists of the infusion of crystalloid and/or colloidal so-
lutions. The goal is the maintenance of normovolemia, 
the result is a dilution of the red cell mass remaining in 
the vasculature (acute normovolemic anemia). The term 
‘anemia tolerance’ refers to both the patient’s physiologi-
cal ability to tolerate even profound stages of acute ane-
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 Abstract 
 Background: The patient’s individual anemia tolerance is 
pivotal when blood transfusions become necessary, but are 
not feasible for some reason. To date, the effects of neuro-
muscular blockade (NMB) on anemia tolerance have not 
been investigated.  Methods: 14 anesthetized and mechani-
cally ventilated pigs were randomly assigned to the Roc 
group (3.78 mg/kg rocuronium bromide followed by contin-
uous infusion of 1 mg/kg/min, n = 7) or to the Sal group (ad-
ministration of the corresponding volume of normal saline, 
n = 7). Subsequently, acute normovolemic anemia was in-
duced by simultaneous exchange of whole blood for a 6% 
hydroxyethyl starch solution (130/0.4) until a sudden de-
crease of total body O 2 consumption (VO 2 ) indicated a critical 
limitation of O 2 transport capacity. The Hb concentration 
quantified at this time point (Hb crit ) was the primary end-
point of the protocol. Secondary endpoints were parameters 
of hemodynamics, O 2 transport and tissue oxygenation.  Re-
sults: Hb crit was significantly lower in the Roc group (2.4  8 
0.5 vs. 3.2  8 0.7 g/dl) reflecting increased anemia tolerance. 
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mia as well as to the anesthesiologist’s willingness to ac-
cept low Hb concentrations  [1] . 
 Owing to the organism’s individual anemia tolerance, 
tissue oxygenation is maintained, although O 2 transport 
capacity decreases progressively with dilutional anemia. 
Acute anemia is initially compensated by increases in 
cardiac output and arteriovenous O 2 extraction  [2] . At 
physiologic Hb concentrations, O 2 supply to the tissues 
(DO 2 ) exceeds total body O 2 demand – reflected by O 2 
consumption (VO 2 ) under rest conditions – by the factor 
3–4  [3] . Even when DO 2 begins to decrease at lower Hb 
concentrations, O 2 supply to the tissues is still sufficient 
to meet their O 2 demand and VO 2 remains constant over 
a wide range of decreasing Hb concentrations (supply in-
dependency of VO 2 ). When DO 2 falls below a critical val-
ue, the amount of O 2 delivered to the tissues becomes 
insufficient to meet their O 2 demand and VO 2 starts to 
decline (supply dependency of VO 2  [4, 5] ). Hb crit is the Hb 
concentration corresponding to the sudden decrease in 
VO 2 and reflects the individual limit of anemia tolerance 
 [6] .
 Neuromuscular blockade (NMB) is an integral part of 
the anesthetic management of a variety of surgical inter-
ventions. While NMB has been demonstrated to decrease 
total body energy expenditure and VO 2  [7, 8] , to date, a 
potential influence on anemia tolerance has not been in-
vestigated. We hypothesized that NMB should increase 
the tolerance of acute normovolemic anemia – reflected 
by a significantly lower value of Hb crit and a higher vol-
ume of blood allowed to be exchanged for hydroxyethyl 
starch (HES).
 Materials and Methods 
 After approval by the local governmental review board, ex-
periments were performed in 20 healthy farm-bred pigs of both 
sexes (body weight 25.8  8 3.7 kg). All animals received good care 
in compliance with the Guide for the Care and Use of Laboratory 
Animals. Prior to the actual study, 5 pilot experiments were per-
formed for dose finding (identification of an adequate dose of ro-
curonium bromide) and to assess potential effects of NMB on 
skeletal muscular VO 2 (mVO 2 ).
 Anesthesia and Ventilation 
 Twelve hours before the experiments, the animals were denied 
food but had free access to water. After intramuscular premedica-
tion with 10 mg/kg ketamine and 1 mg/kg midazolam, anesthesia 
was induced by intravenous injection of 3 mg/kg propofol and 30 
  g/kg fentanyl. Anesthesia was maintained by continuous infu-
sion of propofol (0.16 mg/kg/min), midazolam (0.01 mg/kg/min) 
and fentanyl (0.8   g/kg/min). Estimated fluid losses were re-
placed with a balanced electrolyte solution (3 ml/kg/h). All trade 
names of anesthetics and infusion fluids applied are listed in the 
Appendix. 
 The animals’ tracheas were orally intubated and their lungs 
were ventilated with ambient air at a rate of 14 cycles/min and a 
positive end-expiratory pressure of 5 cm H 2 O (Servo 900B, Sie-
mens Elema, Solna, Sweden). Tidal volume was individually ad-
justed to provide arterial normocapnia and was then maintained 
throughout the entire procedure. Body core temperature was kept 
constant using a warming pad.
 Pilot Experiments 
 For preliminary assessment of mVO 2 , the right femoral artery 
and vein were dissected free from surrounding tissue. An ultra-
sonic flow probe (diameter 2 mm, Transsonic, Ithaca, N.Y., USA) 
was placed around the femoral artery and the femoral vein was 
cannulated with an 18-gauge Teflon catheter (Leader Cath, Vy-
gon, Ecouen, France), which was inserted retrograde for 15 mm. 
An area of 3  ! 5 cm of the adductor muscle of the lower limb was 
dissected free from surrounding tissue for measurement of tissue 
O 2 partial pressure. Thirty minutes after completion of surgical 
preparation, baseline values of mVO 2 and tissue O 2 partial pres-
sure were obtained. Subsequently, the dissected skeletal muscle 
was subjected to tetanic electrical stimulation using a relaxometer 
device (TOF-watch, Organon, Oberschleissheim, Germany) and 
the second data set was recorded (‘stimulation’). After a 30-min 
recovery period, a complete NMB was established with 3.78 mg/
kg of rocuronium bromide (‘relaxation’). In pigs, the ED 95 of ro-
curonium was determined to be 1.26 mg/kg  [9] , so that the used 
dose corresponded with the threefold ED 95 . The final data set was 
obtained 2 min after reversal of NMB with the tenfold dose (37.8 
mg/kg) of sugammadex (‘reversal’). Subsequently, the animals 
were killed by intracardial injection of saturated potassium chlo-
ride solution.
 Study Experiments 
 Instrumentation and Monitoring 
 The animals were placed in supine position and a 5-lead elec-
trocardiogram (II, V5) was used for detection of arrhythmias and 
ST segment changes. A double-lumen catheter (Arrow, Reading, 
Pa., USA) was inserted into the cranial vena cava and a Swan-
Ganz catheter (Baxter, Irvine, Calif., USA) was floated into a 
branch of the pulmonary artery; 6-french introducer sheaths were 
inserted into both the right femoral artery and vein, respectively. 
For continuous measurement of arterial blood pressure and car-
diac output, a thermodilution catheter (Pulsion, Munich, Ger-
many) was placed into the left femoral artery. 
 Experimental Protocol 
 Upon placement of the different measuring devices, a 60-min 
stabilization period was allowed to elapse to achieve stable base-
line conditions. The first data set (‘baseline’) was recorded, and 
appropriate neuromuscular transmission was visualized by as-
sessment of the right foreleg extensor muscle contraction re-
sponse to electric train-of-four stimulation (TOF-watch).
 Thereafter, the animals were randomized to receive either ro-
curonium bromide or normal saline (Roc group, n = 7 vs. Sal 
group, n = 7). In the Roc group, the threefold ED 95 (3.78 mg/kg) 
was administered, followed by continuous infusion of 1 mg/kg/
min. In the Sal group, the animals received the corresponding 
volumes of normal saline. The investigator remained blinded un-
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til the administration of rocuronium or saline was terminated 
and the second data set (‘treatment’) was registered.
 Subsequently, an automated hemodilution protocol was initi-
ated by isovolumic exchange of whole blood for HES (6% HES 
130/0.4, 1 ml/kg/min). The target parameter was the animal’s in-
dividual Hb crit concentration, which was prospectively assessed 
in an investigator-independent manner (see below).
 In the Roc group, the completeness of NMB was confirmed 
every 60 s during the entire hemodilution protocol (TOF stimu-
lation of the foreleg extensor muscle). Therefore, the investiga-
tor needed to be unblinded at the initiation of the hemodilution 
protocol. When Hb crit was met, the final data set was collected 
(‘Hb crit ’) and the animals were killed by intracardial injection of 
saturated potassium chloride solution.
 Assessment of Hb crit 
 Hb crit is the correlate of the critical limitation of DO 2 , and 
marks the onset of total body O 2 supply dependency. The corre-
sponding decrease in VO 2 was detected in an automated and in-
vestigator-independent manner: VO 2 was measured every 60 s 
with a metabolic monitor (Delta-Trac II TM MBM-200, Datex-Eng-
strom, Helsinki, Finland). VO 2 values were simultaneously re-
corded and computed with a specific software (DeltaCrit System) 
 [10] . During the stabilization period, the DeltaCrit System includ-
ed VO 2 values into an online regression analysis and calculated 
mean and standard deviation. During the subsequent hemodilu-
tion period, every minutely obtained VO 2 value was compared to 
the mean value predicted by the DeltaCrit System. When three 
consecutive VO 2 values were outside the predefined range (3  ! 
standard deviation of regression line;  fig. 1 ), a significant decrease 
in VO 2 was assumed and signaled by visual and acoustic com-
puter alerts  [10] .
 Measurements 
 Measurements of hemodynamic and O 2 -derived parameters 
were performed at ‘baseline’, ‘treatment’ and at ‘Hb crit ’. Intravas-
cular blood volume was determined at baseline using the ‘whole-
blood’ method of the indocyanine green indicator dilution tech-
nique, which has already been described in detail elsewhere  [11] . 
The pressure transducers of the cardiovascular catheters were 
connected with a multichannel recorder (Hugo-Sachs, March-
Hugstetten, Germany) and measurement readings were recorded 
with a personal computer. Cardiac output was continuously 
assessed using the transpulmonary thermodilution technique 
(PICCO-Classic monitor, Pulsion, Munich, Germany). Arterial 
and mixed venous blood samples were withdrawn for blood gas 
analysis and assessment of Hb concentration (GEM 3000 and 682 
CO-Oximeter, both Instrumentation Laboratory, Lexington, 
Mass., USA). Calculated parameters were determined as de-
scribed in the Appendix.
 Statistics 
 Statistical analysis was performed with the SAS 9.1 software 
package (SAS Institute, Cary, N.C., USA). Distribution of data was 
assessed with the Shapiro-Wilk test. Normally distributed param-
eters are presented as mean  8 standard deviation, nonnormally 
distributed parameters are displayed as median  8 semi-inter-
quartile range.
 In the case of normal distribution, the time effect on the dif-
ferent variables as well as differences between the groups at the 
investigated time points were tested by repeated analysis of vari-
ance. Post hoc analysis of differences detected with analysis of 
variance was performed with the Student-Newman-Keuls test.
 In the case of nonnormal distribution, the time effect on the 
parameters as well as between-group differences were tested by 
analysis of variance on ranks. Post hoc analysis of differences de-
tected with analysis of variance on ranks was performed with 
Tukey’s test. For all parameters, statistical significance was ac-
cepted at p  ! 0.05.
 The sample sizes were calculated on the basis of a postulated 
power of 85% and a variance of data observed in our previous 
studies with a similar experimental protocol.
 Results 
 Pilot Experiments 
 Following neurostimulation of the lower limb adduc-
tor muscle, skeletal mVO 2 was significantly increased 
( fig. 2 ).
 The increase in mVO 2 was accompanied by an in-
crease in femoral arterial blood flow, while muscular O 2 
extraction rate did not change significantly ( table 1 ).
 After a 30-min recovery period, NMB with rocuroni-
um bromide decreased mVO 2 beyond the baseline level 
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 Fig. 1. Typical example of the continuous VO 2 recording and iden-
tification of Hb crit . VO 2 values collected during the 60 min were 
included in a linear regression analysis and mean and standard 
deviation were calculated. During the hemodilution protocol, ev-
ery current VO 2 value was compared with the mean value deter-
mined during the stabilization period. A critical limitation of 
DO 2 was assumed, when three consecutive VO 2 values fell below 
the lower 3  range. 
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(p = 0.011;  fig. 1 ), which was accompanied by a significant 
decrease in femoral arterial blood flow and a nonsignifi-
cant decrease in muscular O 2 extraction rate ( table 1 ). Af-
ter pharmacologic reversal of NMB, mVO 2 and femoral 
arterial blood flow returned to baseline, which was paral-
leled by a significant increase in muscular O 2 extraction 
rate ( table 1 ). 
 Contrasting the effects on mVO 2 , VO 2 remained un-
changed after neurostimulation, NMB, and after the ad-
ministration of sugammadex.
 Study Experiments 
 Baseline Characteristics 
 No significant differences between the groups were 
observed at baseline ( table 2 ). 
 Effects of Treatment 
 One animal developed a fatal allergic reaction imme-
diately after injection of rocuronium bromide; this ex-
periment was not included in data analysis as the animal 
did not meet the inclusion criterion (completion of hemo-
dilution protocol). 
 While the injection of normal saline was devoid of any 
hemodynamic effect, the administration of rocuronium 
bromide was associated with significant increases in 
heart rate and mean pulmonary artery pressure and non-
significant increases in cardiac index (CI) and pulmo-
nary capillary wedge pressure. Compared with the Sal 
group, the mean pulmonary artery pressure was higher 
and the systemic vascular resistance index was lower in 
animals having received rocuronium bromide (p  ! 0.05; 
 table 2 ).
 Although the O 2 extraction rate was decreased in the 
Roc group (p  ! 0.05 vs. baseline and vs. Sal), NMB did not 
exert a significant change of total body VO 2 ( fig. 3 ). How-
ever, in 5 of the 7 animals of the Roc group, VO 2 decreased 
slightly, while VO 2 only decreased in 2 animals of the Sal 
group. As a consequence, the change of VO 2 relative to 
baseline (  VO 2 ) had a negative sign in the Roc group 
(  VO 2 : –1.7  8 0.8%) and was positive in the Sal group 
(3.2  8 1.9%;  fig. 2 ). 
 Primary Endpoint: Hb crit 
 NMB with rocuronium bromide enabled a more exten-
sive blood for HES exchange: in the Roc group, 2,081  8 
449 ml of blood had been exchanged (vs. 1,433  8 501 ml 
in the Sal group, p = 0.014) until Hb crit was met and the 
hemodilution protocol was terminated. As a consequence, 
a significantly lower value of Hb crit was attained in the Roc 
group (2.4  8 0.5 g/dl vs. 3.2  8 0.7 g/dl, p = 0.015;  fig. 4 ). 
Table 1.  Pilot experiments: parameters of global and regional O2 
transport
Parameter Baseline Stimulation Relaxation Reversal
HR, min–1 7084 6785 7688 7484
MAP, mm Hg 79813 8185 85813 77810
VO2I, ml  min–1  m–2 237813 241819 236820 233816
Q, ml  min–1 8988 13685* 8488* 98810*
SaO2, % 9481 9482 9482 9482
paO2, mm Hg 7788 76810 76813 78810
SfvO2, % 6289 6386 6682 5784*
pfvO2, mm Hg 3383 3683 3583 3282*
tpO2, mm Hg 3089 39823 39811 34824
mO2-ER, % 3589 3386 2984 3985*
H R = Heart rate; MAP = mean arterial pressure; VO2I = total 
body O2 consumption indexed to body surface area; Q = femoral 
arterial blood flow; SaO2, paO2, SfvO2, pfvO2 = arterial and fem-
oral venous O2 saturation and O2 partial pressure; tpO2 = tissue 
O2 partial pressure; mO2 ER = muscular O2 extraction rate. * p < 
0.05 vs. previous.
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 Fig. 2. Skeletal mVO 2 determined in the lower limb adductor mus-
cle (for the calculation of mVO 2 , see Appendix). mVO 2 was as-
sessed in the pilot study at the following time points: (1) after ter-
mination of surgical preparation (‘baseline’), (2) after electrical 
neurostimulation of the muscle (‘stimulation’), (3) after a 30-min 
recovery period and subsequent implementation of NMB (‘relax-
ation’), and (4) after reversal of NMB with sugammadex (‘rever-
sal’). Neurostimulation was associated with a significant increase 
in mVO 2 . NMB decreased mVO 2 beyond the baseline level, while 
the reversal of NMB returned mVO 2 to baseline.  a  p  ! 0.05 vs. pre-
vious time point,  b  p  ! 0.05 vs. baseline. 
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 Secondary Endpoints: Hemodynamics and O 2 
Transport 
 During induction of critical normovolemic anemia, 
heart rate and CI increased in both groups by 38 and 67% 
(p  ! 0.05 vs. baseline), whereas mean aortic pressure and 
coronary perfusion pressure decreased by 23 and 37%, 
respectively (p  ! 0.05 vs. baseline). PVRI decreased by 
10% in the Roc group (nonsignificant vs. baseline) and by 
38% in the Sal group (p  ! 0.05 vs. baseline). Furthermore, 
hemodilution was associated with a decrease of CaO 2 , 
DO 2 , pH and BE by 64, 59, 1 and 49% (p  ! 0.05 vs. base-
line). The O 2 extraction rate only increased in the Roc 
group (p  ! 0.05), which was accompanied by decreases in 
SvO 2 and pvO 2 (p  ! 0.05).
 At Hb crit , the following differences between the groups 
were observed: arterial blood pressure was significantly 
lower in the Roc group, resulting in lower values of mean 
aortic pressure and coronary perfusion pressure (p  ! 
0.05). Due to the lower Hb crit in the Roc group, CaO 2 and 
DO 2 indexed to the body surface area were significantly 
lower than in the Sal group. The lower values of pH and 
base excess (p  ! 0.05) reflect dilutional acidosis related to 
a more profound degree of hemodilution in the Roc 
group. 
 Discussion 
 The main result of the present study is that NMB with 
rocuronium bromide increased the tolerance of acute 
normovolemic anemia, as indicated by a significantly 
lower value of Hb crit , and a higher volume of blood ex-
changed for HES until Hb crit was met. 
 Hb crit represents the ultimate limit of anemia toler-
ance, i.e., the Hb concentration corresponding with a 
critical limitation of DO 2 . When Hb falls short of this 
critical value, the amount of O 2 delivered to the tissues 
becomes insufficient to meet their O 2 demand and VO 2 
starts to decline (onset of O 2 supply dependency of VO 2 ) 
 [4, 5] . In our previous experimental studies, critical nor-
movolemic anemia was associated with 100% mortality if 
no further treatment (e.g. elevation of FiO 2 , transfusion 
of red blood cells, administration of catecholamines, in-
fusion of artificial O 2 carriers) was instantaneously initi-
ated at Hb crit  [12–15] .
 Hb crit has been chosen as the primary endpoint in sev-
eral experimental studies investigating the impact of sev-
eral interventions on the tolerance limit of acute anemia 
and was usually found at values between 1.6 and 3 g/dl 
( table 3 ). Consistently, the value of Hb crit in the Roc group 
Table 2.  Parameters of central hemodynamics and O2 transport ob-
tained at baseline, after treatment with Roc or Sal, and at the Hbcrit
Parameter Group Baseline Treatment Hbcrit
BVI Roc 81813 n.d. n.d.
ml  m–2 Sal 7287 n.d. n.d.
Temperature Roc 37.581.1 37.481.4 37.181.0
° C Sal 37.380.8 37.280.5 37.080.8
HR Roc 7787 93812a 125811a
min–1 Sal 7987 8387 117819a
MAP Roc 73810 76812 49811a
mm Hg Sal 86819 82810 7388a, b
MPAP Roc 2484 3085a, b 2881
mm Hg Sal 2387 2487 2987a
PCWP Roc 5.382.2 8.283.2 7.483.3
mm Hg Sal 5.082.9 5.683.8 7.784.7a
CI Roc 3.980.6 4.680.9 7.381.1a
l  min–1  m2 Sal 3.580.2 3.980.4 7.281.1a
SVI Roc 5384 4984 5789
ml  m–2 Sal 4584 4786 5984a
CVP Roc 5.584.1 5.882.8 7.682.0
mm Hg Sal 6.583.0 5.682.9 8.984.1
SVR Roc 1,7958241 1,3198388 6278474a
dyn–1  s–1  cm–5 Sal 1,6608183 1,5548134b 7428119a
PVRI Roc 383848 431891 248843
dyn–1  s–1  cm–5 Sal 4218116 3788105 218826a
CPP Roc 51810 53812 2585a
mm Hg Sal 64818 5888 4588a, b
VO2I Roc 231820 228822 199828a
ml–1  min–1  m–2 Sal 241818 244814 226816a
DO2I Roc 425878 496874 227894a, b
ml–1  min–1  m–2 Sal 37488 429862 327855a
paO2 Roc 99813 96814 9588
mm Hg Sal 105812 11088 113823
paCO2 Roc 3484 3584 3582
mm Hg Sal 3383 3383 3483
CaO2 Roc 10.881.1 11.181.0 3.580.7a
ml  dl–1 Sal 10.880.6 10.980.9 4.681.0a, b
SvO2 Roc 57810 6288a 53812a
% Sal 5388 5689 61818
O2-ER Roc 43810 3486a, b 50811a
% Sal 4787 4188 41816
pH Roc 7.5580.08 7.4980.11 7.4780.03a, b
Sal 7.5780.04 7.5880.04 7.5280.04a
Base excess Roc 7.584.0 3.585.5 1.482.4a, b
mmol  l–1 Sal 8.482.4 8.382.0 4.681.8a
Lactate Roc 1.781.0 1.781.0 2.181.0
mmol  l–1 Sal 2.180.6 2.080.6 2.080.8
B VI = Blood volume indexed to body surface area; HR = heart 
rate; MAP = mean arterial pressure; MPAP = mean pulmonary ar-
tery pressure; PCWP = pulmonary capillary wedge pressure; SVI = 
stroke volume index; CVP = central venous pressure; SVRI and 
PVRI = systemic and pulmonary vascular resistance index; CPP = 
coronary perfusion pressure; DO2I = O2 delivery indexed to body 
surface area; paO2 = arterial O2 partial pressure; CaO2 = arterial O2 
content; SvO2 = mixed venous O2 saturation; O2 ER = O2 extraction 
rate. Roc group, n = 7; Sal group, n = 7. a p < 0.05 difference vs. base-
line; b p < 0.05 difference between the groups.
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(2.4  8 0.5 g/dl) is comparable to that described in para-
lyzed animals  [13, 15–19] , while the values of Hb crit ob-
tained in nonparalyzed animals are similar to Hb crit ob-
served in the Sal group  [4, 12] . 
 In several experimental studies, a decrease in Hb crit 
demonstrated that anemia tolerance is increased by (1) 
hypothermia (moderate reduction of body core tempera-
ture reduces total body O 2 demand  [16] ), (2) hyperoxic 
ventilation (bioavailability of physically dissolved O 2 is 
excellent in profound anemia  [12, 17, 18] ), (3) infusion of 
norepinephrine (stabilization of coronary perfusion pres-
sure during hemodilution  [13] ), and (4) artificial O 2 car-
riers (maintenance of CaO 2 despite reduced hematocrit 
 [19, 20] ). In contrast, anemia tolerance is decreased by (1) 
hypovolemia (reduction of microcirculatory O 2 supply), 
(2) profound anesthesia (pharmacologic reduction of the 
cardiac output response to hemodilution  [21, 22] ) and (3) 
by coronary artery disease (reduced coronary flow re-
serve  [23] ). 
 During general anesthesia, NMB is usually applied to 
facilitate orotracheal intubation and mechanical ventila-
tion and many surgical procedures (e.g. abdominal or 
thoracic surgery) require NMB. Whether the pharmaco-
logic reduction of skeletal muscular tone by NMB has an 
impact on anemia tolerance has been of minor interest 
and has not yet been investigated. 
 Considering that skeletal muscular mass comprises 
30–40% of total body mass  [24] and that the cross-bridge 
cycle of muscular contraction is highly energy-dependent 
 [25] , it should be expected that NMB reduces skeletal 
mVO 2  and should therefore decrease total body O 2 de-
mand. 
 In part, this assumption is supported by our data. Ac-
tually, the results of our pilot experiments clearly demon-
strate that NMB decreased mVO 2 , regional blood flow to 
the skeletal muscle and muscular O 2 extraction beyond 
their baseline values. Consistently, the reversal of NMB 
with sugammadex – a   -cyclodextrin-based chelator 
with a specific affinity to steroidal relaxants (rocuronium 
 1 vecuronium  1 pancuronium)  [26] – elevated these pa-
rameters and their values returned to the baseline level 
( fig. 2 ;  table 1 ).
 NMB had only a moderate effect on the total body lev-
el. After administration of rocuronium bromide, total 
body O 2 extraction decreased and the negative VO 2 dif-
ference to baseline (  VO 2 ) in the Roc group (vs. a positive 
value of   VO 2 in the Sal group) indicates a slight effect on 
total body VO 2 ( fig. 3 ). Apart from that, rocuronium bro-
mide elicited notable hemodynamic effects, as very high 
doses were needed to achieve complete NMB ( table  2 ). 
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line (  VO 2 ). In 5 out of 7 animals of the 
Roc group, VO 2 decreased slightly (  VO 2 
–1.7  8 0.8%), while in the Sal group, VO 2 
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3.2  8 1.9%, p  ! 0.05 vs. Roc group).  
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 Fig. 4. Hb crit investigated as the primary endpoint of the present 
study. As the hemodilution protocol could be performed more 
extensively in the Roc group, a critical limitation of total body O 2 
supply was met at a significantly lower Hb crit (2.4  8 0.5 g/dl vs. 
3.2  8 0.7 g/dl, p  ! 0.05 vs. Sal). 
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While the transient increase in pulmonary vascular re-
sistance, mean pulmonary artery pressure and pulmo-
nary capillary wedge pressure might have been evoked by 
histamine release, the increases in heart rate and CI are 
probably caused by vagolytic effects, which have been de-
scribed for steroidal relaxants like pancuronium or ro-
curonium  [27] . 
 According to Fick’s principle, the decrease in total 
body O 2 extraction immediately after administration of 
rocuronium might be interpreted as a response to in-
creased CI – always presumed that VO 2 remains con-
stant. However, Muldoon and Theye  [28] reported al-
ready in 1969 that whole-body VO 2 was decreased in dogs 
paralyzed with d-tubocurarine, and some clinical studies 
investigating the effects of NMB on VO 2 reported a re-
duction of total-body VO 2 and energy expenditure by 
NMB in sedated and mechanically ventilated children  [8] 
and in adults suffering acute respiratory failure  [7] , severe 
cerebral trauma  [29] or burn injuries  [30] . Inconsistently, 
other investigators found no effects of NMB on VO 2 in 
deeply sedated intensive care unit patients (Ramsay score 
5)  [31] or in anesthetized patients undergoing cardiac sur-
gery  [32] . 
 The potential of NMB to reduce total body VO 2 might 
therefore depend on the depth of anesthesia. The anes-
thesia regimen applied in the present study (propofol, 
midazolam and fentanyl) has already been used in sev-
eral of our previous investigations  [13, 14, 17] . To the au-
thor’s experience, this anesthesia regimen has proven ap-
propriate for pigs, as it provided sufficient anesthetic 
depth without severely compromising cardiovascular 
function. 
 Under the anesthetic regimen applied in the present 
study, skeletal muscular activity did not substantially 
contribute to total body VO 2 , although NMB did reduce 
mVO 2 , muscular O 2 extraction and regional blood flow 
to the skeletal muscle. 
 Physiologically, blood flow to and within the skeletal 
muscle is regulated by the endothelial/vascular smooth 
muscle unit, which permits the physiological adaptation 
of regional O 2 delivery to the actual metabolic demand 
 [33] . At the site of microcirculation, convective and dif-
fusive O 2 transport is therefore enhanced in the contract-
ing muscle, when compared with the skeletal muscle at 
rest  [34] . Moreover, blood flow to the working muscle 
seems to be augmented during acute anemia: in humans 
Table 3. L imits of acute normovolemic anemia as reflected by the individual Hbcrit in different species
Author Species Anesthesia FiO2 Plasma
substitute
Identification of Hbcrit Hbcrit
g  dl–1
Fontana et al. [37] man (child) isoflurane, sufentanil, vecuronium 1.0 albumin decay of VO2  (retrospectively) 2.1
Van Woerkens
et al. [38]
man
(84 years)
enflurane, fentanyl, pancuronium 0.4 gelatin decay of VO2  (retrospectively) 4
Zollinger et al. [39] man 
(58 years)
propofol, fentanyl, pancuronium 1.0 gelatin ST segment depression 1.1
Cain [4] dog pentobarbital 0.21 dextran decay of VO2  (retrospectively) 3.3
Perez-de-Sá
et al. [16]
pig isoflurane, fentanyl, midazolam, 
vecuronium
0.5 dextran decay of VO2  (retrospectively) 2.380.2
Meier et al. [12] pig propofol, fentanyl 0.21 HES decay of VO2  (prospectively) 3.180.4
Pape et al. [17] pig propofol, fentanyl, midazolam, 
pancuronium
0.21 HES decay of VO2  (prospectively) 2.480.4
Kemming et al. [18] pig midazolam, morphine, pancuronium 0.21 HES ST segment depression 2.680.3
Meisner et al. [19] pig diazepam, morphine, pancuronium 0.21 albumin ST segment depression 2.080.8
Meier et al [13] pig propofol, fentanyl, pancuronium 0.21 HES decay of VO2  (prospectively) 2.680.4
Pape et al. [15] dog propofol, midazolam, fentanyl, 
pancuronium
0.21 HES decay of VO2  (prospectively) 2.780.5
Van der Linden [40] dog thiopental, ketamine, pancuronium 0.21 HES versus 
gelatin
decay of VO2  (retrospectively) 3.680.8
3.581.5
Van der Linden [21] dog thiopental, ketamine (high dose),
pancuronium thiopental,
ketamine (low dose), pancuronium
0.21 HES decay of VO2  (retrospectively) 3.781.4
2.580.6
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undergoing moderate hemodilution and submaximal 
muscular exercise, the increase in muscular blood flow 
was more strongly pronounced than in controls with 
physiologic arterial O 2 content  [35] . This finding suggests 
that particularly in acute anemia, the elimination of mus-
cular activity reduces skeletal muscular blood flow, 
thereby enabling a redistribution of O 2 delivery in favor 
of vital organs. 
 In summary, our data indicate that complete NMB in-
creased the tolerance of acute normovolemic anemia in 
anesthetized pigs. The underlying mechanism most like-
ly involves a reduction of skeletal muscular metabolic O 2 
demand. Although paralyzed individuals may tolerate 
significantly lower Hb concentrations than nonpara-
lyzed, a blood transfusion in clinical practice would usu-
ally be initiated before anemia tolerance is exhausted, es-
pecially since the individual anemia tolerance is strongly 
influenced by comorbidity including cardiovascular dis-
eases or critical illness. However, an allogeneic blood 
transfusion may occasionally be impossible (e.g. refusal 
of blood transfusion for religious reasons, bridging an 
unexpected massive blood loss until compatible blood 
products become available for transfusion, prehospital 
trauma care) and very severe levels of acute normovole-
mic anemia have to be tolerated in these particular situ-
ations. In such extreme conditions, the augmentation of 
anemia tolerance by NMB might play an adjuvant role in 
maintaining DO 2 and oxygenation of vital organs despite 
extremely low Hb levels. 
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 Appendix 
 Calculations 
 Body surface area (BSA) was calculated according to Holt et 
al. [36] from body weight (BW) and a species-dependent constant 
(k = 9 for pigs):
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(1)
 CI was calculated as: 
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CO lCI
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 ­ ­ ®min  m                                                                             
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 where CO = cardiac output. 
 Stroke volume index (SVI) was calculated as:
 2
CI lSVI
HR m
 ¬­ ­ ­ ®                                                                             (3)
 where HR = heart rate. 
 Systemic and pulmonary vascular resistance indices were cal-
culated as:
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 and 
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 respectively, where SVRI = systemic vascular resistance index, 
PVRI = pulmonary vascular resistance index, MAP = mean aortic 
pressure, CVP = central venous pressure, MPAP = mean pulmo-
nary artery pressure, and PCWP = pulmonary capillary wedge 
pressure. 
 Coronary perfusion pressure (CPP) was calculated as:
 CPP = DAP – PCWP (mm Hg),                                                  (6)
 where CPP = coronary perfusion pressure, DAP = diastolic aortic 
pressure, and PCWP = pulmonary capillary wedge pressure. 
 Arterial and mixed venous O 2 contents (CaO 2 and CvO 2 ) were 
calculated as: 
 < >2 2 21 34 0 0031 mlCaO . Hb SaO . paO dl
 ¬   ®  
­­­                        (7)
 and 
 < >2 2 21 34 0 0031 mlCvO . Hb SvO . pvO dl
 ¬­  ­ ­ ®  
                                     (8)
 where SaO 2 and SvO 2 = arterial and mixed venous O 2 saturation 
and paO 2 and pvO 2 = arterial and mixed venous O 2 partial pres-
sure. 
 O 2 delivery was indexed to BSA:
 2 2 2
mlDO I CI CaO
min m
 ¬­ ­ ­ ­­ ®


                                             (9)
 O 2 extraction ratio was calculated as:
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2
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 The relative difference of VO 2 to baseline after treatment was 
calculated as
 	 
22
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100 100 %Treatment
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VOVO
VO
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 Skeletal mVO 2  was calculated as:
 	 
2 2
2 100
CaO CfvO mlmVO Q
min
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                                        (12)
 where Q = femoral arterial blood flow, CaO 2 and CfvO 2 = arte-
rial and femoral venous O 2 content. 
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 For induction and maintenance of anesthesia, the following 
drugs were administered:
 Ketamine (Ketavet TM , Parke-Davis, Berlin, Germany)
 Midazolam (Midazolam TM , Ratiopharm, Ulm, Germany)
 Propofol (Propofol TM , Braun, Melsungen, Germany)
 Fentanyl (Fentanyl TM , Janssen, Neuss, Germany)
 Electrolyte solution (Tutofusin TM , Baxter, Unterschleissheim, 
Germany)
 Rocuronium bromide (Esmeron TM , Essex Pharma, Ober-
schleissheim, Germany)
 Sugammadex (Bridion TM , Essex Pharma, Oberschleissheim, 
Germany)
 The hemodilution protocol was performed with HES 130/0.4, 
Voluven TM , Fresenius Kabi, Bad Homburg, Germany.
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